Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

ZILBRYSQ® (zilucoplan) Is Now Commercially Available in the U.S. for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients Who Are Anti-Acetylcholine Receptor (AChR) Antibody Positive

ZILBRYSQ® (zilucoplan) is now commercially available by prescription in the United States and dispensed by UCB's selected exclusive specialty pharmacy PANTHERx® Rare Pharmacy. ZILBRYSQ is FDA-approved as the first and only self-administered C5 complement inhibitor indicated for the treatment of gMG in adult patients …

EODHD | 03 January 2024

AltaGas' (TSE:ALA) Upcoming Dividend Will Be Larger Than Last Year's

The board of AltaGas Ltd. (TSE:ALA) has announced that it will be paying its dividend of CA$0.2975 on the 29th of March, an increased payment from last year's comparable dividend. The payment will take the dividend yield to 4.0%, which is in line with …

EODHD | 03 January 2024

NIBE Industrier AB (publ) appoints Fredrik Erlandsson as Head of Corporate Communications and Investor Relations

NIBE Industrier AB Fredrik Erlandsson, the current Head of Corporate Communications and Investor Relations at Thule Group (publ), has been appointed Head of Corporate Communications and Investor Relations and a member of NIBE Industrier AB’s Management team. For the past 13 years, Fredrik has …

EODHD | 03 January 2024

ICG Enterprise Trust Plc: Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”) 3 January 2024 Transaction in Own Shares The Company announces that on 2 January 2024 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1222 pence per share. …

EODHD | 03 January 2024

Vistry Group PLC's (LON:VTY) Stock Is Going Strong: Have Financials A Role To Play?

Vistry Group (LON:VTY) has had a great run on the share market with its stock up by a significant 20% over the last month. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually …

EODHD | 03 January 2024

Dr. Martens (LON:DOCS) Is Due To Pay A Dividend Of £0.0156

The board of Dr. Martens plc (LON:DOCS) has announced that it will pay a dividend of £0.0156 per share on the 2nd of February. This makes the dividend yield 6.6%, which will augment investor returns quite nicely. While the dividend yield is important for …

EODHD | 03 January 2024

Brambles' (ASX:BXB) Returns On Capital Are Heading Higher

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. This shows us that it's a …

EODHD | 03 January 2024

Investors in Star Entertainment Group (ASX:SGR) have unfortunately lost 85% over the last five years

Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for those who held The Star Entertainment Group Limited (ASX:SGR) for five whole …

EODHD | 02 January 2024

Keyera Corp. Announces $250 Million Public Note Offering

/NOT FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./ CALGARY, AB, Jan. 2, 2024 /CNW/ - Keyera Corp. (TSX: KEY) ("Keyera") announced today that it has agreed to issue $250 million …

EODHD | 02 January 2024

Brookfield Renewable to Host Fourth Quarter 2023 Results Conference Call

Brookfield Renewable Partners L.P. BROOKFIELD, News, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Brookfield Renewable (NYSE: BEP, BEPC; TSX: BEP.UN, BEPC) (“Brookfield Renewable”) will hold its Fourth Quarter 2023 Conference Call and Webcast on Friday, February 2, 2024 at 9:00 a.m. ET to discuss results …

EODHD | 02 January 2024

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions